Abstract
The aim of the present study was to increase the understanding of veteran experiences with receiving an evidence-based psychotherapy (EBPs) for PTSD (Cognitive Processing Therapy and Prolonged Exposure therapy) in the Veterans Affairs Healthcare System (VA). Eighteen veterans who participated in the study were being seen in the outpatient PTSD clinic at a New England VA and had elected to participate in an EBP. The study assessed veteran experiences with, and outcomes from, treatment through the use of both quantitative and qualitative assessment tools. A rigorous data analytic approach, Consensual Qualitative Research, was applied to narrative data. Results fell into seven domains: Previous EBP & Outcome, Barriers to Treatment, Treatment Process, Treatment Outcome, Treatment Drop Out, and Feelings about Treatment. Overall, veterans reported diverse reactions to the EBPs for PTSD and identified both positive and negative aspects of the treatments. They identified multiple barriers to treatment completion and provided insight into their thoughts and feelings during the treatment protocol. Veterans who chose to drop out of treatment prematurely identified the factors that contributed to this decision. In this way, the study offers an initial but important look at veteran perceptions of and experiences with EBPs for PTSD.
Similar content being viewed by others
Data Availability
The dataset for this study is not stored in a data repository. However, the dataset for this study is fully accessible and will be made available upon request. Please email the corresponding author to obtain the data.
Notes
-
The sample contained one outlier who endorsed a 56-point drop on the PCL from intake to termination and produced a score of “0” on the termination PCL. Removing this case from the analysis would result in a mean symptom drop of 14 points.
-
Refers specifically to Cognitive Processing Therapy or Prolonged Exposure therapy.
-
Refers specifically to Cognitive Processing Therapy or Prolonged Exposure therapy.
References
Trivedi RB, Post EP, Sun H, Pomerantz A, Saxon AJ, Piette JD, ..., Nelson K. Prevalence, comorbidity, and prognosis of mental health among US Veterans. Am J Public Health 2015;105:2564–2569.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: Author; 2013.
Doran JM, O’Shea M, Harpaz-Rotem I. In their own words: clinician experiences and challenges in administering evidenced-based treatments for PTSD in the veterans health administration. Psychiatry Q. 2018;90:11–27.
National Institute for Clinical Excellence. Post-traumatic stress disorder: The management of PTSD in adults and children in primary and secondary care [National Clinical Practice Guideline Number 26]. London: The Royal College of Psychiatrists and the British Psychological Society; 2005.
U.S. Department of Veteran Affairs. How Common is PTSD in Veterans?. 2018. Retrieved from https://www.ptsd.va.gov/understand/common/common_veterans.asp. Retrieved November 8, 2019
National Institute of Mental Health. Post-traumatic stress disorder (PTSD). 2017. Retrieved from https://www.nimh.nih.gov/health/statistics/post-traumatic-stress-disorder-ptsd.shtml. Retrieved November 8, 2019
Petrakis IL, Rosenheck R, Desai R. Substance use comorbidity among veterans with posttraumatic stress disorder and other psychiatric illness. Am J Addict. 2011;20:185–9.
Smith MW, Schnurr PP, Rosenheck RA. Employment outcomes and PTSD symptom severity. Admin Pol Ment Health. 2005;7:89–101.
Chard KM, Schumm JA, Owens GP, Cottingham SM. A comparison of OEF and OIF veterans and Vietnam veterans receiving cognitive processing therapy. J Trauma Stress. 2010;23:25–32.
Tsai J, Harpaz-Rotem I, Pietrzak RH, Southwick SM. The role of coping, resilience, and social support in mediating the relation between PTSD and social functioning in veterans returning from Iraq and Afghanistan. Psychiatry. 2012;75:135–49.
Resick PA, Monson CM, Chard KM. Cognitive processing therapy: veteran and military version. Boston, MA: National Center for PTSD, Women’s health sciences division, VA Boston health care system. J Clin Psychol. 2006;74:898–907.
Foa EB, Hembree EA, Rothbaum BO. Prolonged exposure therapy for PTSD: emotional processing of traumatic experiences (therapist guide). New York: Oxford; 2007.
Rutt BT, Oehlert ME, Krieshok TS, Lichtenberg JW. Effectiveness of cognitive processing therapy and prolonged exposure in the Department of Veteran Affairs. Psychol Rep. 2018;121:282–302.
Watkins LE, Sprang KR, Rothbaum B, Treating PTSD. A review of evidence-based psychotherapy interventions. Front Behav Neurosci. 2018;12:258.
Asmundson GJG. A meta-analytic review of cognitive processing therapy for adults with posttraumatic stress disorder. Cogn Behav Ther. 2018;48:1–14.
Barlow DH. Evidence-based practice: A world view. Clin Psychol-Sci Pr. 2000;7:241–2.
Foa EB, Keane TM, Friedman MJ. Guidelines for treatment of PTSD. J Trauma Stress. 2000;13:539–88.
Horesh D, Qian M, Freedman S, Shalev A. Differential effect of prolonged exposure therapy and cognitive therapy on PTSD symptom clusters: A randomized controlled trial. Psychol Psychother. 2017;90:235–43.
Kline AC, Cooper AA, Rytwinski NK, Feeny NC. Long-term efficacy of psychotherapy for posttraumatic stress disorder: A meta-analysis of randomized controlled trials. Clin Psychol Rev. 2018;59:30–40.
Monson CM, Schnurr PP, Resick PA, Friedman MJ, Young-Xu Y, Stevens SP. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006;74:898–907.
Powers MB, Halpern JM, Ferenschak MP, Gillihan SJ, Foa EB. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin Psychol Rev. 2010;30:635–41.
Resick PA, Nishith P, Weaver TL, Astin MC, Feuer CA. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002;70:867–79.
Doran JM, Pietrzak RH, Hoff R, Harpaz-Rotem I. Psychotherapy utilization and retention in a national sample of veterans with PTSD. J Clin Psychol. 2017;00:1–21.
Doran JM, DeViva J. A naturalistic evaluation of evidence-based treatment for veterans with PTSD. Traumatology. 2018;24:157–67.
Niles BL, Polizzi CP, Voelkel E, Weinstein ES, Smidt K, Fisher LM. Initiation, dropout, and outcome from evidence-based psychotherapies in a VA PTSD outpatient clinic. Psychol Serv. 2018;15:496–502.
Zayfert C, DeViva JC, Becker CB, Pike JL, Gillock KL, Hayes SA. Exposure utilization and completion of cognitive behavioral therapy for PTSD in a “real world” clinical practice. J Trauma Stress. 2005;18:637–45.
Bradley R, Greene J, Russ E, Dutra L, Westen D. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry. 2005;162:214–27.
Resick PA, Wachen JS, Dondanville KA, Pruiksma KE, Yarvis JS, Peterson AL, …, Litz BT. Effect of group vs individual Cognitive Processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: A randomized clinical trial JAMA Psychiatry 2017;74:28–36.
Schottenbauer MA, Glass CR, Arnkoff DB, Tendick V, Gray SH. Nonresponse and dropout rates in outcome studies on PTSD: review methodological considerations. Psychiatry. 2008;71:134–68.
Steenkamp MM. True evidence-based care for posttraumatic stress disorder in military personnel and veterans. JAMA Psychiat. 2016;73:431–2.
Steenkamp MM, Litz BT, Hoge CW, Marmar CR. Psychotherapy for military-related PTSD: A review of randomized clinical trials. JAMA. 2015;314:489–500.
Peterson AL, Luethcke CA, Borah EV, Borath AM, Young-McCaughan S. Assessment and treatment of combat-related PTSD in returning war veterans. J Clin Psychol Med Settings. 2011;18:164–75.
Sayer NA, Rosen CS, Bernardy NC, Cook JM, Orazem RJ, …, Schnurr PP. Context matters: team and organizational factors associated with research of evidence-based psychotherapies for PTSD in the veterans health administration. Admin Pol Ment Health 2017;22;904–913.
Osei-Bonsu PE, Bolton RE, Stirman SW, Eisen SV, Herz L, Pellowe ME. Mental health providers’ decision-making around the implementation of evidence-based treatment for PTSD. J Behav Health Serv Res. 2017;44:213–23.
Corrigan PW, Druss BG, Perlick DA. The impact of mental illness stigma on seeking and participating in mental health care. Psychol Sci Public Interest. 2014;15:37–70.
Harpaz-Rotem I, Rosenheck R, Pietrzak RH, Southwick SM. Determinants of prospective engagement in mental health treatment among symptomatic Iraq/Afghanistan veterans. J Nerv Ment Dis. 2014;202:97–104.
Rozanova J, Noulas P, Smart K, Roy A. Southwick, SM…Harpaz-Rotem, I. "I'm coming home, tell the world I'm coming home." the long homecoming and mental health treatment of Iraq and Afghanistan war veterans. Psychiatry Q. 2015;87:427–43.
Sherman N. Stoic warriors: the ancient philosophy behind the military mind. Oxford: Oxford University Press; 2005.
Bisson JI, Ehlers A, Matthews R, Pilling S. Psychological treatments for chronic post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry. 2007;190:97–104.
Watts BV, Schnurr PP, Mayo L, Young-Xu Y, Weeks WB, Friedman MJ. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2013;74:e541–50.
Jaeger JA, Echiverri A, Zoellner LA, Post L, Feeny NC. Factors associated with choice of exposure therapy for PTSD. IJBCT. 2009;5:294.
Kehle-Forbes SM, Meis LA, Spoont MR, Polusny MA. Treatment initiation and dropout from prolonged exposure and cognitive processing therapy in VA outpatient clinic. Psychol Trauma. 2016;8:107–14.
Weathers FW, Blake DD, Schnurr PP, Kaloupek DG, Marx BP, Keane TM. The Life Events Checklist for DSM-5 (LEC-5). 2013. http://www.ptsd.va.gov of subordinate document. Retrieved October 28, 2019
Monson CM, Gradus JL, Young-Xu Y, Schnurr PP, Price JL, Schumm JA. Change in posttraumatic stress disorder symptoms: do clinicians and patients agree? Psychol. 2008;20:131–8.
Weathers FW, Huska JA, Keane TM. PCL-C for DSM-IV. Boston: National Center for PTSD-Behavioral Science Division; 1991.
Muran JC. A relational approach to understanding change: plurality and contextualism in a psychotherapy research program. Psychother Res. 2002;12:113–38.
Hill CE, Thompson BJ, Williams EN. A guide to conducting consensual qualitative research. Couns Psychol. 1997;25:517–72.
Hill CE, Knox S, Thompson BJ, Williams EN, Hess SA, Ladany N. Consensual qualitative research: an update. J Couns. 2005;52:196–205.
Hundt NE, Barrera TL, Arney J, Stanley MA. “It’s worth it in the end”: veterans’ experiences with prolonged exposure and cognitive processing therapy. Cogn Behav Pract. 2017;24:50–7.
Mott JM, Mondragon S, Hundt NE, Beason-Smith M, Grady RH, Teng EJ. Characteristics of U.S. veterans who begin and complete prolonged exposure and cognitive processing therapy for PTSD. J Trauma Stress. 2014;27:265–73.
Larsen SE, Bellmore A, Bogin RL, Holens P, Lawrence KA, Pacella-LaBarbara ML. An initial review of residual symptoms after empirically supported trauma-focused cognitive behavioral psychological treatment. J Anxiety Disord. 2017;63:26–35.
Castillo DT, Lacefield K, Baca JC, Blankenship A, Qualls C. Effectiveness of group-delivered cognitive therapy and treatment length in women veterans with PTSD. Behav Sci. 2014;4:31–41.
Levi O, Wald I, Svetlitsky V, Zusmanovitz S, Parasha E, …, Fruchter E. Combat-related multifaceted trauma-focused group therapy: a pilot study. J Nerv Ment Dis 2017;205:133–139.
Gray MJ, Schorr Y, Nash W, Lebowitz L, Amidon A, … Litz BT. Adaptive disclosure: an open trial of a novel exposure-based intervention for service members with combat-related psychological stress injuries. Behav Ther 2012;43:407–415.
Nash WP. Combat/operational stress adaptations and injuries. Combat stress injury: theory, research and management. New York: Routledge; 2007. p. 33–64.
Buchholz KR, Bohnert KM, Pfeiffer PN, Valenstein M, Ganoczy D, et al. Reengagement in PTSD psychotherapy: a case-control study. Gen Hosp Psychiatry. 2017;48:20–4.
Trombley C. MyVA: Putting veterans first by reducing wait times and providing better experience. VAntage Point: Official Blog of the U.S. Department of Veterans Affairs. December 21, 2016. Retrieved from: https://www.blogs.va.gov/VAntage/33779/myva-putting-veterans-first-by-reducing-wait-times-and-providing-better-experience/. Retrieved October 28, 2019
Veterans Affairs Medical Scribe Pilot Act of 2017, H.R. 1848, 115th Congress; 2017.
Institute of Medicine (US) and National TromblAcademy of Engineering (US)Roundtable on Value & Science-Driven Health Care. Engineering a learning healthcare system: A look at the future (workshop summary). Washington, D.C.: National Academies Press (US); 2011.
Kopta SM, Howard KI, Lowry JL, Beutler LE. Patterns of symptomatic recovery in psychotherapy. J Consult Clin Psychol. 1994;62:1009–16.
Perry JC, Banon E, Ianni F. Effectiveness of psychotherapy for personality disorders. Am J Psychiatry. 1999;156:1312–21.
Minnen A, Foa EB. The effect of imaginal exposure length on outcome of treatment for PTSD. J Trauma Stress. 2006;19:427–38.
Galovski TE, Blain LM, Mott JM, Elwood L, Houle T. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012;80:968–81.
Hoge CW. Interventions for war-related posttraumatic stress disorder: meeting veterans where they are. JAMA. 2011;306(5):549–51.
APA Task Force on Evidence-Based Practice. Evidence-based practice in psychology. Am Psychol. 2006;61:271–85. https://doi.org/10.1037/0003-066X.61.4.271.
Freiheit SR, Vye C, Swan R, Cady M. Cognitive-behavioral therapy for anxiety: is dissemination working? Behav Ther. 2004;27:25–32.
Kazdin AE. Evidence-based treatment and practice: new opportunities to bridge clinical research and practice, enhance the knowledge base, and improve patient care. Am Psychol. 2008;63:146–59.
Norcross JC, Wampold BE. What works for whom: tailoring psychotherapy to the person. J Clin Psychol. 2011;67:127–32.
Courtois CA, Brown LS. Guideline orthodoxy and resulting limitations of the American Psychological Association’s clinical practice guideline for the treatment of PTSD in adults. Psychotherapy. 2019;56:329–39.
Norcross JC, Wampold BE. Relationships and responsiveness in the psychological treatment of trauma: the tragedy of the APA clinical practice guideline. Psychotherapy. 2019;56:391–9.
Shedler J. Selling bad therapy to trauma victims. Psychol Today [blog post]. 2017, November 19. Retrieved from: https://www.psychologytoday.com/us/blog/psychologically-minded/201711/selling-bad-therapy-trauma-victims. Retrieved March 4, 2020
Crouch M, McKenzie H. The logic of small samples in interview-based qualitative research. Soc Sci Inf. 2006;45:483–99.
Acknowledgements
The authors would like to sincerely thank the clinicians and veterans who contributed to this study. We are grateful for their participation and very much appreciate their valuable insights.
Funding
This research was partially supported by the VA Connecticut Psychology Department Bell Kerns Research Award.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This Study and its Procedures Were Performed in Compliance with the Tenets of the Declaration of Helsinki
Conflict of Interest
The authors declare that they have no conflict of interest.
Disclosures
The authors have no relevant financial or non-financial interests to disclose.
Ethics Approval/IRB Approval
Approval was obtained by the Human Subjects Committee of the VA Connecticut Medical Center.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix 1
Appendix 1
Veteran Pre-Treatment Interview
I am going to ask you a few questions about your choice to begin an evidence-based, trauma-focused treatment for PTSD Footnote 2 and any concerns that you might have about it. Do you have any questions for me before we begin?
- 1.
When did you decide to begin a trauma-informed treatment?
- 2.
When did you first learn about the treatment options available for PTSD?
- 3.
How long did you consider beginning a trauma-informed treatment before making the decision to do so?
- 4.
What factors contributed to your decision to begin a trauma-informed treatment?
- 5.
What do you know about trauma-informed treatments for PTSD?
- 6.
Have you ever previously engaged in a trauma-informed treatment? (If yes: How did it go?)
6a. Did you complete the treatment? (If no: What got in the way or What factors led you to drop out?)
- 7.
Do you have any concerns or negative thoughts or feelings about beginning a trauma-informed treatment? (If yes: What are they?)
7a. (If yes to above) Have you discussed your concerns with anyone? How did that go?
- 8.
On a scale of 1–10, how committed do you feel to completing the treatment, with “1” being not at all committed and “10” being totally committed.
- 9.
Do you feel that there are any barriers in the way that might interfere with you being able to complete the treatment?
- 10.
Is there anything you wish that your therapist knew about you in advance, or anything you are hoping that they will do or say during your treatment?
Veteran Post-Treatment Interview
I am going to ask you a few questions about your experience in an evidence-based, trauma-focused treatment for PTSD Footnote 3 to find out what went well and what could have been better. Do you have any questions for me before we begin?
- 1.
Which trauma-informed treatment did you complete (CPT or PE)? Why? Did you have a preference for one over the other?
- 2.
Can you provide me with a brief overview of how things went in the treatment?
2a. What went well? What could have gone better?
- 3.
Did you have any negative feelings about the treatment or your therapist during the therapy?
3a. If yes to above: Did you express these feelings to your therapist? (If yes: What happened? How did he/she respond?)
- 4.
Do you feel that you benefitted from the treatment? (If yes: How so?)
- 5.
Did you complete a full course of the treatment? (If no, add “drop questions” below)
5b (If yes): Was there ever a time where you felt like quitting or dropping out? What happened? What made you decide to stay?
- 6.
Do you feel that the treatment resolved your PTSD? (If no: Are you still experiencing symptoms of PTSD? What do you still need to work on?)
- 7.
How did you feel about the length of treatment? (Too long/too short/just right?)
- 8.
What about the treatment worked well for you? Was there anything that did not work so well, or anything you wish had been done differently?
- 9.
Do you feel that there are important issues or concerns about your experience that were not addressed in the therapy? (Please describe.)
- 10.
Are there traumatic experiences you had, or parts of your trauma, that you were not comfortable sharing or bringing up with your therapist?
10a. Have you ever told anyone about these experiences?
10b. Do feelings of guilt and shame get in the way of sharing these experiences?
- 11.
Did your therapist check-in with you about your thoughts and feelings about the treatment? (Do you feel that he/she responded to your feelings or concerns?)
- 12.
Is there anything that you think could be improved about the treatment you were offered?
- 13.
How do you feel about the [type of EBP received] treatment? Would you recommend it to other veterans?
Drop Out Questions
I am interested in understanding more about why you decided to end the treatment before completing all of the sessions. We know that some veterans choose not to complete the treatment, but we don’t understand why that is. Any information you could provide about what happened would be very helpful. This information will not be shared with your clinician or anyone outside of the research team.
- 1.
Why did you decide to end therapy before you completed the protocol? What factors led up to this decision?
- 2.
Did you discuss wanting to drop out with your therapist before you dropped out? (If yes: How did that conversation go?)
- 3.
Was there anything that would have made you continue the treatment?
- 4.
Do you think you will try a trauma-informed treatment again in the future? Why or why not?
Rights and permissions
About this article
Cite this article
Doran, J.M., O’Shea, M. & Harpaz-Rotem, I. In Their Own Words: Veteran Experiences with Evidence-Based Treatments for PTSD in the Veterans Health Administration. Psychiatr Q 92, 961–980 (2021). https://doi.org/10.1007/s11126-020-09861-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11126-020-09861-z